ACADIA Pharmaceuticals
ACAD
$15.21
Share price
-11.21%
Change (1 day)
-29.02%
Change (1 year)
Categories
ACADIA Pharmaceuticals (ACAD) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.31 B
According to ACADIA Pharmaceuticals's latest financial reports the company's total liabilities are $0.31 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
ACADIA Pharmaceuticals - Total liabilities on balance sheet (from 2003 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.31 B | 69.27% |
| 2022-12-31 | $0.18 B | 17.69% |
| 2021-12-31 | $0.15 B | 2.33% |
| 2020-12-31 | $0.15 B | 85.14% |
| 2019-12-31 | $84.04 M | 37.51% |
| 2018-12-31 | $61.12 M | 24.18% |
| 2017-12-31 | $49.22 M | 15.16% |
| 2016-12-31 | $42.74 M | 93.11% |
| 2015-12-31 | $22.13 M | 38.61% |
| 2014-12-31 | $15.96 M | 128.55% |
| 2013-12-31 | $6.98 M | -70.4% |
| 2012-12-31 | $23.6 M | 169.72% |
| 2011-12-31 | $8.75 M | 0.53% |
| 2010-12-31 | $8.7 M | -76.82% |
| 2009-12-31 | $37.56 M | 221.49% |
| 2008-12-31 | $11.68 M | -43.41% |
| 2007-12-31 | $20.65 M | -7.75% |
| 2006-12-31 | $22.38 M | -3.24% |
| 2005-12-31 | $23.13 M | 138.87% |
| 2004-12-31 | $9.68 M | -88.52% |
| 2003-12-31 | $84.36 M | 50.35% |
| 2002-12-31 | $56.11 M | 1269.62% |
| 2001-12-31 | $4.09 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $101.94 B | 32,039.24% | 🇺🇸 USA |
 Pfizer PFE | $137.21 B | 43,157.43% | 🇺🇸 USA |
 Eli Lilly LLY | $51.04 B | 15,992.67% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $82.48 B | 25,903.39% | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | $0.10 B | -67.36% | 🇺🇸 USA |